New Delhi, March 10 (IANS) An Apple-led study has validated women's experiences of a wide range of menstrual cycle symptoms, including some that are less commonly known or discussed that will help destigmatise menstrual symptoms.The Apple Women's Health Study team at Harvard T.H. Chan School of Public Health on Wednesday released a preliminary study update, offering pioneering scientific insights on women and their menstrual symptoms, made possible through the innovative research methodology of the Research app.The update, based on a cohort of 10,000 participants and inclusive of varying ages and races across the US, highlights how large-scale, longitudinal research on menstruation can help advance the science around women's health.The study found that most frequently tracked symptoms were abdominal cramps, bloating and tiredness, all of which were experienced by more than 60 per cent of participants who logged symptoms.More than half of the participants who logged symptoms reported acne and headaches. Some less widely recognised symptoms, like diarrhoea and sleep changes, were tracked by 37 per cent of participants logging symptoms."These findings take us a step further in validating and destigmatising period symptoms," said Dr Sumbul Desai, Apple's vice president of Health.Initial analysis also suggests these symptom trends hold true across a wide range of demographics, including age, race, and geographic location.For example, across Black, Hispanic, and white participants, the most commonly reported symptoms were abdominal cramps, bloating and tiredness."Our study will help to achieve a more gender equal future, in which all people with menstrual cycles have access to the health services and menstrual products needed to feel safe and empowered," said Dr Michelle Williams, Dean of the Faculty at Harvard Chan School.The team will further investigate the preliminary data and submit a detailed analysis, including a breakdown of methods, for peer review and journal publication."The preliminary data we are sharing today suggests women across the country have a shared experience of a wide range of menstrual symptoms, and that this natural monthly occurrence is something we should be having more discussions about," said Dr Shruthi Mahalingaiah, one of the study's principal investigators.--IANSna/
An Apple-led study has validated womens experiences of a wide range of menstrual cycle symptoms, including some that are less commonly known or discussed, that will help destigmatise menstrual symptoms.
The Apple Women's Health Study team at Harvard T.H. Chan School of Public Health on Wednesday released a preliminary study update, offering pioneering scientific insights on women and their menstrual symptoms, made possible through the innovative research methodology of the Research app.
The update, based on a cohort of 10,000 participants and inclusive of varying ages and races across the US, highlights how large-scale, longitudinal research on menstruation can help advance the science around women's health.
The study found that most frequently tracked symptoms were abdominal cramps, bloating and tiredness, all of which were experienced by more than 60 per cent of participants who logged symptoms.
More than half of the participants who logged symptoms reported acne and headaches. Some less widely recognised symptoms, like diarrhoea and sleep changes, were tracked by 37 per cent of participants logging symptoms.
"These findings take us a step further in validating and destigmatising period symptoms," said Dr Sumbul Desai, Apple's vice president of Health.
Initial analysis also suggests these symptom trends hold true across a wide range of demographics, including age, race, and geographic location.
For example, across Black, Hispanic, and white participants, the most commonly reported symptoms were abdominal cramps, bloating and tiredness.
"Our study will help to achieve a more gender equal future, in which all people with menstrual cycles have access to the health services and menstrual products needed to feel safe and empowered," said Dr Michelle Williams, Dean of the Faculty at Harvard Chan School.
The team will further investigate the preliminary data and submit a detailed analysis, including a breakdown of methods, for peer review and journal publication.
"The preliminary data we are sharing today suggests women across the country have a shared experience of a wide range of menstrual symptoms, and that this natural monthly occurrence is something we should be having more discussions about," said Dr Shruthi Mahalingaiah, one of the study's principal investigators. (IANS)
As per a study published in the 'British Medical Journal', menstrual pain, heavy bleeding and low mood may be linked to nearly nine days of lost productivity per woman every year. A focus group study indicates that 84.1 per cent women reported the occurrence of menstrual cramps or primary dysmenorrhea during their menstrual cycles.
Periods are usually associated with mild, tolerable lower abdomen or back discomfort but the pain (dysmenorrhoea) can be severe enough to interfere with day-to-day activities. The existing solutions in modern healthcare and allopathic medicine system are known to have harmful side effects in long term.
In its endeavour to offer a more sustainable, herbal and ayurvedic solution for medical cramps, India's first research to retail venture in the Ayurvedic Cannabis (Bhang) sector, HempStreet has announced the launch of medicinal cannabis based Trailokya Vijaya Vati.
The medicine has cannabis as one of its key ingredients and is effective in soft tissue muscle pains like menstrual cramps and spasms.
Shrey Jain, Co-Founder at HempStreet says: "Menstruation as a topic is highly stigmatised in our country. Period pain is often ignored by making a significant part of women lifestyle and working hours stressful and painful. But the fact is that women have even described the cramping pain as 'almost as bad as having a heart attack'. On an average, a woman goes through around 450 menstrual cycles throughout her lifetime. Irony is that the available solutions in modern medical science possess threat of serious harmful effects in case of long term consumption. Trailokya Vijaya Vati aims at providing a reliable, safe and ayurvedic solution to the women of 21st century.
He adds: "Hempstreet is working in conjunction with top notch scientists to conduct R&D around safe medication by leveraging the immense potential and natural power of Cannabis. Today HempStreet boasts of 15 approved products and a world-class research partnership with Council of Scientific and Industrial Research (CSIR). We have successfully reached out to extensive doctor network of 43,000 doctors and 230 clinics to provide medical cannabis medicine, primarily to alleviate the huge menstrual pain relief crisis in India. The company strive to bring an effective and responsible usage of Cannabis, especially on the pain relief front, to its potential addressable patient base of over 35 million individuals."
The Cannabis Sativa plant, which encompasses hemp, cannabis, and marijuana, contains more than 100 different chemicals called cannabinoids. These are used to treat many diseases and conditions, including chronic pain, insomnia, anxiety, menstrual cramps, muscle spasms, mental health, epilepsy, and multiple sclerosis, sexual disorders, and more. The legal Cannabis industry is currently one of the fastest growing industries in the world. According to a report by Grand View Research Inc., the global legal marijuana market is predicted to reach $146.4 billion by the end of 2025.
(Puja Gupta can be contacted at email@example.com)
In India there are 335 Million of menstruating women , representing nearly 30% of the nation’s population.
Menstruation has for long been a taboo topic that was only (if every talked about) discussed behind close doors. The recent wave of awareness around menstrual hygiene and its importance for female wellbeing has been pivotal.
However, one crucial point of discussion often gets missed in this conversation, that needs to be addressed. Menstrual cramps and spasms affect over 80% of the menstruating women in India, and often no heed is paid to it. It has a direct correlation with productivity, and cramps on an average result in almost 9 days of lost productivity for women every year!
The fact that period leaves are being offered only offers solution to the problem for a limited section. Think about a new mother who is also a homemaker, juggling between managing the household as well as the tantrums of a toddler. Is period leave a solution for her? Can she even take a 5 second break from the duty of caring for her child? Should she continue to work in pain and let this monthly cycle take a toll on her body?
Allopathic pain-killers and analgesics provide some respite, and majority of women aware about them become dependent. These ephemeral remedies often have immediate side-effects, ranging from an over-worked liver to rashes on the skin, which in turn snow-ball into major disorders in the longer run. With 12 years being the global average for the onset of menstruation and 41 years being that for menopause, a women on average goes through around 400 menstrual cycles in a lifetime, which requires the consumption of around 2,800+ of these allopathic tablets to counter the unbearable pain. To put things into perspective, the degree of pain experienced is often described to be tantamount to a heart attack!
There is a need for a sustainable solution that is not harming the body in the longer run. More importantly, there is a need to normalize the conversation around menstrual cramps. #LetsNotWhisper anymore and announce to the world the pain that is being endured, the degree of it and what it leads to. Its important for women to know that there is a better, more sustainable solution out there that does not harm your body in the longer run. Let’s work towards ensuring Every Period is a Painless Period globally !
This has been a focal point of our research HempStreet, and we do believe that we do have a more responsible and sustainable solution to combating and serving a third of our population that has been constantly underserved.
London - Researchers, including one of Indian-origin, have found that menstrual dysfunction is more prevalent in young athletes than among non-athletes of a similar age.
The study, published in the Scandinavian Journal of Medicine & Science in Sports, conducted among members of sports clubs who exercised at least four times a week (athletes) and non-athletes.
"The current data of athletes and non-athletes in adolescence (14-16 years) and subsequently in young adulthood (18-20 years) were investigated," said study authors from the University of Jyvaskyla in Finland.
In this study, menstrual dysfunction was defined as follows: primary amenorrhea, prolonged menstrual cycle (below 35 days) or absence of menses for at least three consecutive months (secondary amenorrhea).
The findings showed that in adolescence, 18 per cent of both athletes and non-athletes reported menstrual dysfunction.
However, eight per cent of the athletes reported primary amenorrhea (absence of menses by the age of 15) in contrast to the non-athletes group, where the prevalence of primary amenorrhea was zero per cent.
In young adulthood, the prevalence of menstrual dysfunction in athletes was 39 per cent, while six per cent of the non-athletes reported menstrual dysfunction.
"We know from previous studies that one of the most common reasons for menstrual dysfunction is low energy availability," said study author Suvi Ravi.
The present study also assessed body weight dissatisfaction among the participants.
The results showed that athletes were more satisfied with their weight and had less desire to lose weight than non-athletes did.
Despite this, in both age groups about 20 per cent of the athletes and about 40 per cent of the non-athletes reported body weight dissatisfaction.
"This is concerning since we know that body weight dissatisfaction can result in disordered eating," Ravi said.
"Attention should be paid to young people's body weight dissatisfaction as well as menstrual dysfunction in order to prevent future health problems," he noted. (IANS)
‘Trailokya Vijaya Vati’ is one of the most potent classical medicines in the formulations having Cannabis as its key ingredients. The literal meaning of ‘Trailokya Vijaya Vati’ is a win over the outer three worlds. The medicine has a direct effect on motor neurons or ‘Vaat- Vaahini Naadi’ and therefore is as a drug providing quick relief or ‘Aashukari’ as per Ayurveda. Therefore, it provides quick results in the ailments related to various types of pain.
Ayurvedic Classical Medicine- Reference: Ayurved Sara Sangraha
Composition: Each tablet of ‘Trailokya Vijaya Vati’ contains 62.5 mg of Vijaya (Cannabis sativa linn) dried leaves, 62.5 mg of Vansh lochan (Bambusa arundianacea), and excipients q.s.
Cannabis medicine for chronic pains, joint pains
Effective for muscular spasms and sciatica pain
Effective for Menstrual cramps, pain associated with Dysmenorrhoea
Provides relief from Colic pain, effective in the treatment of Colitis, IBS, and Diarrhoea
Curbs Insomnia & Anxiety
Improves quality of sleep and controls seizures
Reduces fatigue and provides relief from Neuropathic pain
Mitigates side-effects of Chemotherapy
Effective for Renal colic and abdominal pains
Mechanism of Action:
Cannabinoids produce analgesia by acting on multiple pain targets within the peripheral and CNS by activating specific receptors throughout the body, in particular CB1 which are found predominantly in CNS and CB2 receptors found in cells involved with the immune system. Besides acting on cannabinoid CB1/CB2, they may reduce pain through interaction with the putative non-CB1/CB2 cannabinoid G protein-coupled receptors (GPCR55 or GPCR18) and opioid or serotonin (5-HT) receptors (1)
Hunger levels are determined by a substance in the human body called ghrelin, which is known as the ‘hunger hormone’. The hormone is released by the stomach, intestines, and brain, as it stimulates and manages appetite. Cannabis triggers ghrelin levels and stimulates appetite (2)
IBS, vomiting & Diarrhoea-
Cannabinoids predominately mediate inhibitory pathways in the gastrointestinal tract through reduction of vagal cholinergic tone. CB2 modulate inflammation, whereas CB1 control central functions, including pain control, satiety, nausea, and vomiting. The distribution and concentration of the endocannabinoid system in specific tissues demonstrate the physiology of cannabinoids in the gastrointestinal tract and offer possible drug targets for the management of inflammatory bowel disease.(3)
Dosage: One tablet twice a day or as directed by the Physician.
It is advisable to start at a low dose as dosage may vary according to disease state and conditions. Dose may also vary from person to person. It is best to follow the Physician’s advice to find the right dose.
Route of Administration: Oral
Diet- Cow Milk & Ghee, processed Chaach (Butter Milk with Jeera or as advised by the physician), nutritious, healthy, freshly prepared, and easily digestible meals
Lifestyle- Regular body workout as per the body strength, Drink warm water throughout the day, and Early dinner.
Apathya (To be avoided)
Diet- Excessive Spicy, Cold, Dry, Reheated, Junk, and Heavy to digest meals.
Lifestyle- Exposure to a dry and hot environment, Late night dinner, and improper sleep
CAUTION: Schedule E-1 drug. To be taken strictly under medical supervision
Side-Effects & Safety:
Trailokya Vijaya Vati is safe when taken orally as a prescription medication with dosage as directed by the physician.
Precautions & Warnings-
Allergy- Do not take this medicine if you are allergic to cannabis or any of the ingredients of this medicine
Pregnancy & lactation- This medicine is strictly not recommended during pregnancy or lactation. The effect of this medicine on pregnant women and lactating mothers has not been studied. Therefore, it is strictly not advisable for Pregnant and Lactating Women.
Paediatrics- Similarly, since its effect has not been studied on paediatric population, it is not to be given to children below 16 years of age.
Heart disease- It might cause palpitations, fluctuations in blood pressure. Patients suffering with heart disease should take this strictly under the doctor’s supervision.
Surgery- Taking this along with anaesthesia or sedative medications might cause too much sleepiness. It is advised to stop it at least a week before scheduled surgery.
This medicine is safe if taken as per the advised dose. No conclusive evidence found for any kind of drug interaction. If taking this product along with other medicines, please seek your doctor’s advice before starting this medicine. If both Ayurvedic and allopathic medicines are advised together, then its best to take the medicines at least after a gap of 20-30 minutes, or as directed by the physician.
Drugs for Sedative medications:
Taking Cannabis containing medicines along with sedative medicines can cause too much sleepiness. Consult your doctor before taking this medicine along with any sedative medications.
Drugs that control Blood sugar levels-
No conclusive evidence found for any kind of drug interaction with medicines that control blood sugar levels. It is considerably safe to take with drugs that control blood sugar levels.
Over dosage might cause drowsiness, light headedness, palpitations, and fluctuations in blood pressure, panic attacks. In case of overdose, get medical help immediately.
Keep out of reach of children
Store at 5 - 32 degree Celsius
Protect from heat, light, and moisture
Do not use if the blister is open/broken
Do not use after expiry.
DO NOT take alcohol if under cannabis medication
DO NOT drive or operate any machine while under cannabis medication.
Cannabinoids as pharmacotherapies for neuropathic pain:
Rahn EJ, Hohmann AG
Neurotherapeutics. 2009 Oct; 6(4):713-37.
Mol Cell Endocrinol. 2013 Jan 30; 365(2): 303–308.
Gastroenterol Hepatol (N Y). 2016 Nov; 12(11): 668–679.
Hempstreet Medicare Pvt Ltd-
Hempstreet is India's first research to retail venture in the ayurvedic cannabis sector. We are working in conjunction with top-notch scientists to conduct R&D around safe medication utilizing cannabis to be provided via our network of over 60,000 medical practitioners and 1000 clinics around India. We strive to bring an effective and responsible usage of cannabis, especially on the pain relief front, to our potential patient base of over 35 million individuals. Being the first player with such scale off the bat, we have voluntarily taken on the responsibility of defining industry standards in this sunrise sector, be it world-class research, supply chain tracking, or the responsible and regulated formulation and dispensing of cannabis-based medication.
For any queries or feedback- Customer care: firstname.lastname@example.org or call us at +91 9020774400
To buy Trialokya Vijaya Vati click on this link- https://nirogstreet.com/medicine/hempstreet/trailokya-vijaya-vati-2